Catherine R Fedorenko
Overview
Explore the profile of Catherine R Fedorenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
563
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panattoni L, McDermott C, Li L, Sun Q, Fedorenko C, Sanchez H, et al.
J Clin Oncol
. 2022 Nov;
41(8):1610-1617.
PMID: 36417688
Purpose: The COVID-19 pandemic-related disruptions in health care delivery might have affected end-of-life care in patients with cancer. We examined changes in place of death and hospice support for Medicaid...
2.
Lawson M, Lee C, Hippe D, Chennupati S, Fedorenko C, Malone K, et al.
J Natl Compr Canc Netw
. 2021 Jul;
19(10):1156-1164.
PMID: 34330103
Background: The purpose of this study was to determine factors associated with receipt of screening mammography by insured women before breast cancer diagnosis, and subsequent outcomes. Patients And Methods: Using...
3.
Goulart B, Chennupati S, Fedorenko C, Ramsey S
Clin Lung Cancer
. 2021 Mar;
22(5):e723-e733.
PMID: 33685820
Introduction: We assessed the proportion of patients with advanced epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC) who receive tyrosine kinase inhibitors (TKIs)...
4.
Goulart B, Unger J, Chennupati S, Fedorenko C, Ramsey S
JCO Oncol Pract
. 2020 Dec;
17(2):e130-e139.
PMID: 33284732
Purpose: We investigated the association of out-of-pocket (OOP) costs for tyrosine kinase inhibitors (TKIs) with overall survival (OS) in epidermal growth factor receptor ()- and anaplastic lymphoma kinase ()-positive advanced...
5.
Ramsey S, Hall I, Smith J, Ekwueme D, Fedorenko C, Kreizenbeck K, et al.
J Geriatr Oncol
. 2020 Aug;
12(2):305-311.
PMID: 32739353
Objectives: Studies of local stage prostate cancer survivors suggest that treatments carry risk of persistent impotence, incontinence, and bowel dysfunction. To examine impacts of cancer type and side effects on...
6.
Miles R, Lee C, Sun Q, Bansal A, Lyman G, Specht J, et al.
J Natl Compr Canc Netw
. 2019 Jul;
17(7):813-820.
PMID: 31319393
Background: The purpose of this study was to assess advanced imaging (bone scan, CT, or PET/CT) and serum tumor biomarker use in asymptomatic breast cancer survivors during the surveillance period....
7.
Bansal A, Koepl L, Fedorenko C, Li C, Smith J, Hall I, et al.
J Cancer Educ
. 2017 Feb;
33(2):325-331.
PMID: 28238032
Information sources about prostate cancer treatment and outcomes are typically designed for patients. Little is known about the availability and utility of information for partners. The objectives of our study...
8.
Ramsey S, Bansal A, Fedorenko C, Blough D, Overstreet K, Shankaran V, et al.
J Clin Oncol
. 2016 Jan;
34(9):980-6.
PMID: 26811521
Purpose: Patients with cancer are more likely to file for bankruptcy than the general population, but the impact of severe financial distress on health outcomes among patients with cancer is...
9.
Ramsey S, Zeliadt S, Blough D, Moinpour C, Hall I, Smith J, et al.
J Sex Med
. 2013 Oct;
10(12):3135-43.
PMID: 24118980
Introduction: In this prospective study of localized prostate cancer patients and their partners, we analyzed how partner issues evolve over time, focusing on satisfaction with care, influence of cancer treatment,...
10.
Goulart B, Reyes C, Fedorenko C, Mummy D, Satram-Hoang S, Koepl L, et al.
J Oncol Pract
. 2013 May;
9(1):42-50.
PMID: 23633970
Purpose: Little is known about how referrals to different cancer specialists influence cancer care for non-small-cell lung cancer (NSCLC). Among Medicare enrollees, we identified factors of patients and their primary...